Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

528
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
528
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

553
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
553
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

556
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
556
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

404
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
404
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

451
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
451
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

549
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
549

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The mother during pregnancy and the puerperium: Detailed data abstracted from the clinical obstetric records of ALSPAC pregnancies.

Wellcome open research·2024
Same author

The ALSPAC fetal and neonatal resource: detailed data abstracted from the clinical records of the new-born.

Wellcome open research·2024
Same author

ALSPAC parents' descriptions of childhood stresses in their parents and grandparents.

Wellcome open research·2022
Same author

Ancestral childhood environmental exposures occurring to the grandparents and great-grandparents of the ALSPAC study children.

Wellcome open research·2020
Same author

Grand-maternal smoking in pregnancy and grandchild's autistic traits and diagnosed autism.

Scientific reports·2017
Same author

Care homes receive 'solid gold' accreditation for implementing the gold standard framework.

Nursing older people·2016

Related Experiment Video

Updated: Mar 13, 2026

Tissue Collection and RNA Extraction from the Human Osteoarthritic Knee Joint
06:06

Tissue Collection and RNA Extraction from the Human Osteoarthritic Knee Joint

Published on: July 22, 2021

7.1K

New guidelines for osteoarthritis.

Karen Birmingham

    Nursing Older People
    |October 14, 2016
    PubMed
    Summary

    Osteoarthritis is not an inevitable part of aging. New guidelines from the National Institute for Health and Clinical Excellence (NICE) confirm that effective treatments are available for osteoarthritis patients.

    Area of Science:

    • Rheumatology
    • Geriatrics
    • Public Health

    Background:

    • Osteoarthritis (OA) is frequently misconstrued as an unavoidable consequence of aging.
    • This misconception has historically led to patient disempowerment and suboptimal care.
    • Previous clinical guidance often lacked definitive treatment pathways for OA.

    Purpose of the Study:

    • To challenge the notion that osteoarthritis is solely a natural part of aging.
    • To introduce new guidelines that advocate for proactive OA management.
    • To inform healthcare professionals and patients about available interventions.

    Main Methods:

    • Review of existing OA management strategies.
    • Development of evidence-based clinical guidelines by the National Institute for Health and Clinical Excellence (NICE).

    More Related Videos

    Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain
    07:19

    Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain

    Published on: March 24, 2023

    6.2K
    Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model
    07:32

    Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model

    Published on: May 6, 2020

    13.4K

    Related Experiment Videos

    Last Updated: Mar 13, 2026

    Tissue Collection and RNA Extraction from the Human Osteoarthritic Knee Joint
    06:06

    Tissue Collection and RNA Extraction from the Human Osteoarthritic Knee Joint

    Published on: July 22, 2021

    7.1K
    Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain
    07:19

    Author Spotlight: Fu's Subcutaneous Needling for Knee Osteoarthritis Pain

    Published on: March 24, 2023

    6.2K
    Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model
    07:32

    Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model

    Published on: May 6, 2020

    13.4K
  • Dissemination of new recommendations to healthcare providers.

    • Main Results:

    • The publication of new NICE guidelines for osteoarthritis management.
    • A shift in clinical perspective, emphasizing that OA is treatable.
    • Empowerment of patients with the knowledge that interventions are available.

    Conclusions:

    • Osteoarthritis should not be dismissed as an inevitable aspect of aging.
    • The new NICE guidelines provide a framework for effective OA treatment.
    • Patients can now be assured that 'nothing can be done' is an outdated and inaccurate statement regarding OA management.